Trial: 202006062

A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC) – 10301

Phase

I/II

Principal Investigator

Gay, Hiram

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov